LUMA Vision wins FDA approval for VERAFEYE system
The company also highlights Dr. Devi G Nair's presentation at the HRX innovation summit and invites labs to inquire about 2027 systems.
See the latest news and media coverage for LUMA Vision. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical device company developing interventional cardiac imaging technology
lumavision.comLast updated
In short: LUMA Vision secured expanded FDA clearance for VERAFEYE ahead of a planned early 2027 commercial launch.
The company also highlights Dr. Devi G Nair's presentation at the HRX innovation summit and invites labs to inquire about 2027 systems.
Dr. Devi G Nair presented on intracardiac imaging for electrophysiology navigation, highlighting rapid atrial reconstruction, real-time 2D and 4D imaging and automated imaging-plane adjustment.
The four-dimensional catheter-based imaging system was used and enrolled in the LUMINIZE clinical study at Mater Private Network, Dublin, under Professor Gabor Széplaki.
LSP leads the round with Atlantic Bridge and Enterprise Ireland; the funds advance product development, clinical trials and US commercialisation of its Verafeye 4D cardiac imaging system.
Latest Clearance Expands VERAFEYE's Capabilities as the Company Prepares for Commercial Launch in Early 2027 DUBLIN, Sept. 9, 2026 /PRNewswire/ -- LUMA Vision, a medtech...
The US Food and Drug Administration (FDA) has cleared LUMA Vision’s Verafeye catheter-based imaging ...
DUBLIN, April 16, 2025 /PRNewswire/ -- LUMA Vision Ltd., an innovative leader in advanced cardiac imaging and navigation, today announced the FDA clearance of its...
Luma Vision Ltd. raised $22 million in financing that will allow the company to secure U.S. FDA approval and prepare for commercialization of its 4D...
Track LUMA Vision and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.